Search research articles
Contact Us
Filters
Showing results (41-50 of 134) with videos related to
Page
of 14
Sort By:
EMBO Molecular Medicine
|
March 15, 2025
MHC-I upregulation by macbecin II in the solid tumors potentiates the effect of active immunotherapy
Ravindra Pramod Deshpande, Kerui Wu, Shih-Ying Wu, et al.
Oncogene
|
November 29, 2023
Functional evaluation of dendritic cells and extracellular vesicles as immunotherapy for breast cancer
Feng Lyu, Kerui Wu, Shih-Ying Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 10, 2009
p53 represses c-Myc through induction of the tumor suppressor miR-145
Mohit Sachdeva, Shoumin Zhu, Fangting Wu, et al.
Oncotarget
|
January 5, 2018
Stromal cell extracellular vesicular cargo mediated regulation of breast cancer cell metastasis via ubiquitin conjugating enzyme E2 N pathway
Krishna C Vallabhaneni, Patrice Penfornis, Fei Xing, et al.
Cells
|
January 8, 2025
Co-Inhibition of tGLI1 and GP130 Using FDA-Approved Ketoconazole and Bazedoxifene Is Synergistic Against the Growth and Metastasis of HER2-Enriched and Triple-Negative Breast Cancers
Sara Manore, Chuling Zhuang, Mariana K Najjar, et al.
Breast Cancer Research and Treatment
|
February 7, 2019
ID2 and GJB2 promote early-stage breast cancer progression by regulating cancer stemness
Yin Liu, Puspa R Pandey, Sambad Sharma, et al.
Cell Research
|
December 5, 2012
The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage
Ali Zhang, Nanjiang Zhou, Jianguo Huang, et al.
Nature Communications
|
July 2, 2025
Ghrelin-induced neuronal NPY promotes brain metastasis in lung cancer patients with low BMI
Abhishek Tyagi, Shih-Ying Wu, Jee-Won Kim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 1, 2024
Tumor-intrinsic CDC42BPB confers resistance to anti-PD-1 immune checkpoint blockade in breast cancer
Ravindra Pramod Deshpande, Kerui Wu, Shih-Ying Wu, et al.
Science Advances
|
May 1, 2023
Engineering an active immunotherapy for personalized cancer treatment and prevention of recurrence
Kerui Wu, Feng Lyu, Shih-Ying Wu, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 134) with videos related to
Sort By:
Page
of 14
EMBO Molecular Medicine
|
March 15, 2025
MHC-I upregulation by macbecin II in the solid tumors potentiates the effect of active immunotherapy
Ravindra Pramod Deshpande, Kerui Wu, Shih-Ying Wu, et al.
Oncogene
|
November 29, 2023
Functional evaluation of dendritic cells and extracellular vesicles as immunotherapy for breast cancer
Feng Lyu, Kerui Wu, Shih-Ying Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 10, 2009
p53 represses c-Myc through induction of the tumor suppressor miR-145
Mohit Sachdeva, Shoumin Zhu, Fangting Wu, et al.
Oncotarget
|
January 5, 2018
Stromal cell extracellular vesicular cargo mediated regulation of breast cancer cell metastasis via ubiquitin conjugating enzyme E2 N pathway
Krishna C Vallabhaneni, Patrice Penfornis, Fei Xing, et al.
Cells
|
January 8, 2025
Co-Inhibition of tGLI1 and GP130 Using FDA-Approved Ketoconazole and Bazedoxifene Is Synergistic Against the Growth and Metastasis of HER2-Enriched and Triple-Negative Breast Cancers
Sara Manore, Chuling Zhuang, Mariana K Najjar, et al.
Breast Cancer Research and Treatment
|
February 7, 2019
ID2 and GJB2 promote early-stage breast cancer progression by regulating cancer stemness
Yin Liu, Puspa R Pandey, Sambad Sharma, et al.
Cell Research
|
December 5, 2012
The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage
Ali Zhang, Nanjiang Zhou, Jianguo Huang, et al.
Nature Communications
|
July 2, 2025
Ghrelin-induced neuronal NPY promotes brain metastasis in lung cancer patients with low BMI
Abhishek Tyagi, Shih-Ying Wu, Jee-Won Kim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 1, 2024
Tumor-intrinsic CDC42BPB confers resistance to anti-PD-1 immune checkpoint blockade in breast cancer
Ravindra Pramod Deshpande, Kerui Wu, Shih-Ying Wu, et al.
Science Advances
|
May 1, 2023
Engineering an active immunotherapy for personalized cancer treatment and prevention of recurrence
Kerui Wu, Feng Lyu, Shih-Ying Wu, et al.
Page
of 14